Submit Deal

DYNACURE

Summary

Dynacure operates as a bio-technology company. The Company develops therapies for the treatment of centronuclear myopathies. Dynacure serves clients in France.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 41 M

Avg. Deal Size£ 41 M

Market Context

Senior Management

Stephane van Rooijen
CEO

Sort

stephane van rooijen

CEO at DYNACURE

Manager

Deal

£ 41 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy